| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/23/2023 | Landos Biopharma, Inc. | LABP | Grant | Stock Option (right to buy) | 18k | $0.33 | $5.9k | | 05/23/2023 |
| 01/26/2023 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Common Stock | 3.6k | $0.00 | $0 | | 01/26/2023 |
| 01/26/2023 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Stock Option (Right to Buy) | 16.2k | $5.94 | $96.2k | | 01/26/2023 |
| 06/17/2022 | Landos Biopharma, Inc. | LABP | Grant | Stock Option (right to buy) | 18k | $0.79 | $14.2k | | 06/17/2022 |
| 02/04/2022 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Common Stock | 2.8k | $0.00 | $0 | | 02/04/2022 |
| 02/04/2022 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Stock Option (Right to Buy) | 12.4k | $10.40 | $128.7k | | 02/04/2022 |
| 12/17/2021 | Landos Biopharma, Inc. | LABP | Grant | Stock Option (right to buy) | 253.5k | $4.95 | $1.3M | | 12/17/2021 |
| 05/13/2021 | Landos Biopharma, Inc. | LABP | Grant | | 36k | $10.20 | $367.2k | | 05/13/2021 |
| 01/28/2021 | Esperion Therapeutics, Inc. | ESPR | Grant | Stock Option (right to buy) | 175k | $32.12 | $5.6M | | 01/28/2021 |
| 01/15/2021 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Stock option (right to buy) | 16.5k | $12.60 | $207.9k | | 01/15/2021 |
| 12/30/2020 | Esperion Therapeutics, Inc. | ESPR | Exercise | Stock Option (right to buy) | 10.7k | $2.10 | $22.4k | | 12/30/2020 |
| 03/11/2020 | Esperion Therapeutics, Inc. | ESPR | Purchase | Common Stock | 2.5k | $43.00 | $107.5k | | 03/11/2020 |
| 02/28/2020 | Esperion Therapeutics, Inc. | ESPR | Purchase | Common Stock | 5k | $49.00 | $245k | | 02/28/2020 |
| 01/08/2020 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Stock option (right to buy) | 100k | $2.07 | $207k | | 01/08/2020 |
| 01/02/2020 | Esperion Therapeutics, Inc. | ESPR | Grant | Common Stock | 23.2k | $0.00 | $0 | | 01/02/2020 |
| 01/02/2020 | Esperion Therapeutics, Inc. | ESPR | Grant | Stock Option (right to buy) | 104.2k | $61.34 | $6.4M | | 01/02/2020 |
| 11/15/2019 | Esperion Therapeutics, Inc. | ESPR | Gift | Common Stock | 365 | $0.00 | $0 | | 01/02/2020 |
| 11/11/2019 | Esperion Therapeutics, Inc. | ESPR | Gift | Common Stock | 2k | $0.00 | $0 | | 01/02/2020 |
| 11/06/2019 | Esperion Therapeutics, Inc. | ESPR | Purchase | Common Stock | 5k | $36.98 | $184.9k | | 11/06/2019 |
| 09/06/2019 | Esperion Therapeutics, Inc. | ESPR | Purchase | Common Stock | 2.5k | $35.25 | $88.1k | | 09/04/2019 |
| 09/04/2019 | Esperion Therapeutics, Inc. | ESPR | Purchase | Common Stock | 4.9k | $34.22 | $166k | | 09/04/2019 |
| 09/04/2019 | Esperion Therapeutics, Inc. | ESPR | Purchase | Common Stock | 148 | $33.42 | $4.9k | | 09/04/2019 |
| 08/01/2019 | Esperion Therapeutics, Inc. | ESPR | Purchase | Common Stock | 5k | $39.56 | $197.8k | | 08/01/2019 |
| 06/28/2019 | Esperion Therapeutics, Inc. | ESPR | Purchase | Common Stock | 5k | $46.00 | $230k | | 06/28/2019 |
| 03/29/2019 | Esperion Therapeutics, Inc. | ESPR | Purchase | Common Stock | 5k | $40.00 | $200k | | 03/29/2019 |
| 03/20/2019 | Esperion Therapeutics, Inc. | ESPR | Purchase | Common Stock | 5k | $43.48 | $217.4k | | 03/20/2019 |
| 03/14/2019 | Esperion Therapeutics, Inc. | ESPR | Purchase | Common Stock | 5k | $48.73 | $243.6k | | 03/14/2019 |
| 02/26/2019 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Stock option (right to buy) | 35k | $3.96 | $138.6k | | 02/26/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 5.2k | $20.91 | $108.9k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 5.2k | $24.18 | $126.4k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 11k | $78.58 | $864.4k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 8.8k | $180.98 | $1.6M | | 02/15/2019 |
| 11/28/2018 | Esperion Therapeutics, Inc. | ESPR | Grant | Stock Option (right to buy) | 110k | $52.38 | $5.8M | | 11/28/2018 |
| 06/13/2018 | Loxo Oncology, Inc. | LOXO | Grant | Director Stock Option (right to buy) | 8.8k | $180.98 | $1.6M | | 06/13/2018 |
| 06/08/2018 | Loxo Oncology, Inc. | LOXO | Exercise | Director Stock Option (right to buy) | 2.6k | $24.18 | $62.5k | | 06/08/2018 |
|